Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.375ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.375ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.375EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.375EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.375ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.375ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.432EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.432EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.432ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.432ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.432EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.432EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.432ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.432ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.241EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.241EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.241ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.241ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.241EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.241EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.241ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.241ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.298EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.298EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.298ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.298ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.298EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.298EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.298ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.298ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.433EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.433EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.433ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.433ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.433EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.433EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.433ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.433ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.39EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.39ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.39ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.39EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.39EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.561EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.561EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.561ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.561ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used